Key Findings:  Cannabigerol (CBG) and cannabidivarin CBDV showed neuroprotective and anti-inflammatory properties in an in vitro model of ischemia, and could lead to potential therapeutic uses in ischemic strokes.
Type of Study:  Laboratory Study
Study Result:  Positive
Research Location(s):  United Kingdom
Year of Pub:  2021
Cannabinoids Studied:  Cannabidiol (CBD), Cannabigerol (CBG), Cannabinoid (unspecified), Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV)
Phytocannabinoid Source:  Unspecified
Route of Administration:  In vitro
Citation:  Stone NL, et al. Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood-Brain Barrier Under Ischemic Conditions. Cannabis Cannabinoid Res. 2021; 6:315-326. doi: 10.1089/can.2020.0159
Authors:  Stone NL, England TJ, O'Sullivan SE